Le Lézard
Classified in: Health
Subject: ATY

Block & Leviton LLP Announces It Has Filed A Class Action Against MiMedx Group, Inc. (MDXG)



BOSTON, Feb. 24, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, announces that it has filed a class action against MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG) and certain of its officers for violations of the federal securities laws.

If you purchased MiMedx shares between March 7, 2013 through February 19, 2018 inclusive (the "Class Period") and wish to serve as a lead plaintiff, you must move the Court no later than April 25, 2018. As a member of the class, you may seek to file a motion to serve as a lead plaintiff or take no action and remain an absent class member. If you wish to become involved in the litigation or have questions about your legal rights, you are encouraged to contact attorney Bradley Vettraino at (617) 398-5600, by email at bradley@blockesq.com, or by visiting www.blockesq.com/mdxg.    

In December of 2016, MiMedx was sued by two former employees alleging wrongful termination in relation to their reporting of a "channel-stuffing scheme" to "fraudulently recognize revenue" with regard to a particular distribution contract. MiMedx denied these claims. And in September 2017, when market analysts published reports purportedly corroborating these allegations, among others, MiMedx again denied any wrongdoing and sued for defamation.

Then, on February 20, 2018, pre-market, MiMedx announced that the Company's audit committee "has engaged independent legal and accounting advisors to conduct an internal investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices at the Company. Company executives are also reviewing, among other items, the accounting treatment of certain distributor contracts."

On this news, the Company's stock fell more than 39% to close at $8.75 on February 20, 2018, causing tens of millions of dollars in losses to investors.

The complaint, filed in U.S. Federal court for the Northern District of Georgia alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that (i) MiMedx was engaged in a "channel-stuffing" scheme designed to inappropriately recognize revenue that had not yet been realized; (ii) the Company lacked adequate internal controls over financial reporting; and (iii) that as a result of the foregoing, MiMedx's publicly disseminated financial statements were materially false and misleading.

Confidentiality to whistleblowers or others with information relevant to this investigation is assured.

Block & Leviton LLP is a Boston-based law firm representing investors nationwide. The firm's lawyers have collectively been prosecuting securities cases on behalf of individual and institutional investors for over 50 years, and have recovered billions of dollars on their behalf. Block & Leviton's investigations into corporate wrongdoing were recently covered by the New York Times.

The court in which the action is pending is located at 75 Ted Turner Drive, SW, Atlanta, GA 30303.

This notice may constitute attorney advertising.

CONTACT:

Block & Leviton LLP 
Bradley J. Vettraino  
155 Federal Street, Suite 400 
Boston, MA 02110 
(617) 398-5600 
bradley@blockesq.com 

SOURCE Block & Leviton LLP


These press releases may also interest you

at 17:00
Namaste Technologies Inc. ("Namaste" or the "Company") is pleased to announce that the Company's wholly-owned subsidiary, Cannmart Inc. ("Cannmart") has received its Access to Cannabis for Medical Purposes Regulations ("ACMPR") medical cannabis...

at 16:21
A small county in south Texas joined by two Employer-Teamsters Locals filed a joint motion in federal court on Friday seeking an injunction directing the nation's three largest prescription drug plan providers, known as Pharmacy Benefit Managers...

at 16:10
CollPlant , a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant human, "rhCollagen"), today announced financial results for the second quarter ended June 30, 2018 and...

at 16:00
DALLAS, Sept. 21, 2018 /PRNewswire-PRWeb/ -- The Light Up To Live Foundation, a charity founded by Randall and Sherry Reed, is honored to be hosting the upcoming Valor Charity Events taking place this weekend, September 21-22. The events will consist...

at 16:00
Aurora Cannabis Inc. ("Aurora" or the "Company") , today announced that it has scheduled its conference call to discuss the results for its fourth quarter ended June 30, 2018. The call will be hosted on Tuesday, September 25th, 2018 at 11:00 a.m....

at 15:55
Long island based Good Pharmaceutical Development Company LLC is proud to announce the appointment of Shep Messing, legendary Olympic and professional soccer goalkeeper, as the Director of Professional Athletic Affairs and Promotions. In this role,...




News published on 24 february 2018 at 07:34 and distributed by: